Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms (2007)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.1139/g07-016
- Subjects: EXPRESSÃO GÊNICA; EVOLUÇÃO MOLECULAR; NEOPLASIAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LEOPOLDINO, Andréia M. et al. Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms. Genome, v. 50, n. 5, p. 451-462, 2007Tradução . . Disponível em: https://doi.org/10.1139/g07-016. Acesso em: 13 fev. 2026. -
APA
Leopoldino, A. M., Carregaro, F., Silva, C. H. T. de P. da, Feitosa, O., Mancini, U. M., Freitas, J. M., & Tajara, E. H. (2007). Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms. Genome, 50( 5), 451-462. doi:10.1139/g07-016 -
NLM
Leopoldino AM, Carregaro F, Silva CHT de P da, Feitosa O, Mancini UM, Freitas JM, Tajara EH. Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms [Internet]. Genome. 2007 ; 50( 5): 451-462.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1139/g07-016 -
Vancouver
Leopoldino AM, Carregaro F, Silva CHT de P da, Feitosa O, Mancini UM, Freitas JM, Tajara EH. Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms [Internet]. Genome. 2007 ; 50( 5): 451-462.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1139/g07-016 - Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
- Current topics in computer-aided drug design
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
- RNA interference in drug discovery
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
Informações sobre o DOI: 10.1139/g07-016 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
